Literature DB >> 24319859

Using MoCA-Thai to evaluate cognitive impairment in patients with schizophrenia.

Suwanna Arunpongpaisal1, Akekalak Sangsirilak.   

Abstract

BACKGROUND: Schizophrenia is a chronic devastating illness with specific effects on cognitive function. A few studies have been performed on Asian patients.
OBJECTIVE: To examine prevalence of cognitive impairment and associated factors in Thai patients with schizophrenia. MATERIAL AND
METHOD: A descriptive cross-sectional study of patients with schizophrenia that were selected consecutively from a psychiatric outpatient clinic at Srinagarind Hospital, Khon Kaen University between June 2008 andDecember 2009 was conducted. The Montreal Cognitive Assessment-Thai version (MoCA-T) test was used to evaluate cognitive functions. Associated factors such as age of onset, type of antipsychotics were assessed by collecting data from medical records. Data analysis used descriptive statistics, and univariate analysis used Chi-square.
RESULTS: Seventy-five patients with schizophrenia were recruited The majority of cases was single, male, had low education, and manifested paranoia. The prevalence of cognitive impairment was 81.3%. Significant factors associated with cognitive impairment were the year of education lower than 12 (OR = 9.25, 95% CI 1.90-45.03, p = 0.002) and those who had taken typical and combined antipsychotic drugs (OR = 5.97, 95% CI 1.66-21.55, p = 0.005).
CONCLUSION: Thai patients with schizophrenia showed a high prevalence of cognitive impairment. Therefore, clinicians should assess cognitive function and cognitive remedy

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24319859

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  2 in total

1.  Prevalence, Influencing Factors, and Clinical Characteristics of Cognitive Impairment in Elderly Patients With Schizophrenia.

Authors:  Guojun Liu; Xiaoying Zhang; Xiaoning Huo; Wei Li
Journal:  Front Psychiatry       Date:  2022-06-06       Impact factor: 5.435

2.  Psychometric utility of the international HIV dementia scale and Montreal Cognitive Assessment in HIV-associated asymptomatic neurocognitive impairment.

Authors:  Stephen L Aita; Quanhathai Kaewpoowat; Saowaluck Yasri; Amaraporn Rerkasem; Kittipan Rerkasem; Janejit Choovuthayakorn; Somsanguan Ausayakhun; Kevin Robertson; Robert M Roth; Nathaniel M Robbins
Journal:  J Neurovirol       Date:  2021-06-29       Impact factor: 2.643

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.